Clinical implications of cell‐of‐origin epigenetic characteristics in non‐functional pancreatic neuroendocrine tumors.

MLA

Dreijerink, Koen MA, et al. “Clinical Implications of Cell‐of‐origin Epigenetic Characteristics in Non‐functional Pancreatic Neuroendocrine Tumors.” Journal of Pathology, vol. 256, no. 2, Feb. 2022, pp. 143–48. EBSCOhost, https://doi.org/10.1002/path.5834.

APA

Dreijerink, K. M., Hackeng, W. M., Singhi, A. D., Heaphy, C. M., & Brosens, L. A. (2022). Clinical implications of cell‐of‐origin epigenetic characteristics in non‐functional pancreatic neuroendocrine tumors. Journal of Pathology, 256(2), 143–148. https://doi.org/10.1002/path.5834

Chicago

Dreijerink, Koen MA, Wenzel M Hackeng, Aatur D Singhi, Christopher M Heaphy, and Lodewijk AA Brosens. 2022. “Clinical Implications of Cell‐of‐origin Epigenetic Characteristics in Non‐functional Pancreatic Neuroendocrine Tumors.” Journal of Pathology 256 (2): 143–48. doi:10.1002/path.5834.